← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 2, 2015Last known activity
Aug 9, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (18 distinct, 15 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Recent trials (15)
- NCT07152639CollaboratorPhase 3Aug 9, 2025
- NCT07048353CollaboratorEarly Phase 1Jul 28, 2025
- NCT06683066CollaboratorPhase 1Dec 4, 2024
- NCT06696820CollaboratorPhase 4Dec 1, 2024
- NCT06714084CollaboratorN/AOct 8, 2024
- NCT06265051CollaboratorPhase 2/Phase 3Apr 9, 2024
- NCT06345365CollaboratorPhase 3Jan 18, 2024
- NCT06503094CollaboratorPhase 1/Phase 2Jan 14, 2024
- NCT06009991CollaboratorN/AJul 17, 2023
- NCT05329155CollaboratorN/AJul 20, 2022
- NCT05159947CollaboratorPhase 3Dec 31, 2021
- NCT05044117CollaboratorPhase 3Oct 31, 2021
- NCT04008251CollaboratorPhase 1Jul 1, 2019
- NCT03366324CollaboratorPhase 1Jan 1, 2018
- NCT02965092CollaboratorPhase 1/Phase 2Dec 2, 2015
Details
- Last known activity
- Aug 9, 2025